Brief: Recipharm, Kancera cooperate to manufacture clinical trial supply
Sept 14 (Reuters) - RECIPHARM AB (PUBL) RECIb.ST
* RECIPHARM AND KANCERA KANC.ST COLLABORATE TO MANUFACTURE
CLINICAL TRIAL SUPPLY
* AS PART OF COLLABORATION, CO TO DEVELOP PREPARATION THAT
IS REQUIRED FOR RELEASE OF KAND567 FROM CAPSULES AND
MANUFACTURING PHARMACEUTICAL PRODUCT
Source text for Eikon: ID:nWkr6Cj7Gt
Further company coverage: RECIb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing